ATA159197A - Pharmazeutisches präparat enthaltend vitamin k-abhängige einzelfaktoren - Google Patents

Pharmazeutisches präparat enthaltend vitamin k-abhängige einzelfaktoren

Info

Publication number
ATA159197A
ATA159197A AT0159197A AT159197A ATA159197A AT A159197 A ATA159197 A AT A159197A AT 0159197 A AT0159197 A AT 0159197A AT 159197 A AT159197 A AT 159197A AT A159197 A ATA159197 A AT A159197A
Authority
AT
Austria
Prior art keywords
pharmaceutical preparation
preparation containing
containing vitamin
individual factors
dependent individual
Prior art date
Application number
AT0159197A
Other languages
English (en)
Other versions
AT409334B (de
Inventor
Yendra Dr Linnau
Peter Dr Turecek
Hans-Peter Schwarz
Original Assignee
Immuno Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to AT0159197A priority Critical patent/AT409334B/de
Application filed by Immuno Ag filed Critical Immuno Ag
Priority to PCT/AT1998/000224 priority patent/WO1999015196A1/de
Priority to SK402-2000A priority patent/SK4022000A3/sk
Priority to HU0003681A priority patent/HUP0003681A1/hu
Priority to EP98944886A priority patent/EP1015020A1/de
Priority to BR9812222-3A priority patent/BR9812222A/pt
Priority to AU92449/98A priority patent/AU743102B2/en
Priority to CA002304396A priority patent/CA2304396A1/en
Priority to JP2000512565A priority patent/JP2001517636A/ja
Priority to NO20001415A priority patent/NO20001415L/no
Publication of ATA159197A publication Critical patent/ATA159197A/de
Application granted granted Critical
Publication of AT409334B publication Critical patent/AT409334B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4833—Thrombin (3.4.21.5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
AT0159197A 1997-09-19 1997-09-19 Pharmazeutisches präparat enthaltend vitamin k-abhängige einzelfaktoren AT409334B (de)

Priority Applications (10)

Application Number Priority Date Filing Date Title
AT0159197A AT409334B (de) 1997-09-19 1997-09-19 Pharmazeutisches präparat enthaltend vitamin k-abhängige einzelfaktoren
SK402-2000A SK4022000A3 (en) 1997-09-19 1998-09-17 PHARMACEUTICAL SUBSTANCE CONTAINING VARIOUS VITAMIN K-DEPENDENTì (54) FACTORS
HU0003681A HUP0003681A1 (hu) 1997-09-19 1998-09-17 K-vitamin-függő egyedi faktorokat tartalmazó gyógyszerkészítmény
EP98944886A EP1015020A1 (de) 1997-09-19 1998-09-17 Pharmazeutisches präparat enthaltend vitamin k-abhängige einzelfaktoren
PCT/AT1998/000224 WO1999015196A1 (de) 1997-09-19 1998-09-17 Pharmazeutisches präparat enthaltend vitamin k-abhängige einzelfaktoren
BR9812222-3A BR9812222A (pt) 1997-09-19 1998-09-17 Preparação farmacêutica separada de complexo de protrombina, preparação diagnóstica, e, utilização de uma preparação
AU92449/98A AU743102B2 (en) 1997-09-19 1998-09-17 Pharmaceutical substance containing various vitamin K-dependent factors
CA002304396A CA2304396A1 (en) 1997-09-19 1998-09-17 A pharmaceutical preparation comprising vitamin k-dependent single factors
JP2000512565A JP2001517636A (ja) 1997-09-19 1998-09-17 ビタミンｋ依存性単一因子を含む医薬調製物
NO20001415A NO20001415L (no) 1997-09-19 2000-03-17 Farmasøytikum inneholdende vitamin-K-avhengige faktorer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT0159197A AT409334B (de) 1997-09-19 1997-09-19 Pharmazeutisches präparat enthaltend vitamin k-abhängige einzelfaktoren

Publications (2)

Publication Number Publication Date
ATA159197A true ATA159197A (de) 2001-12-15
AT409334B AT409334B (de) 2002-07-25

Family

ID=3516739

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0159197A AT409334B (de) 1997-09-19 1997-09-19 Pharmazeutisches präparat enthaltend vitamin k-abhängige einzelfaktoren

Country Status (10)

Country Link
EP (1) EP1015020A1 (de)
JP (1) JP2001517636A (de)
AT (1) AT409334B (de)
AU (1) AU743102B2 (de)
BR (1) BR9812222A (de)
CA (1) CA2304396A1 (de)
HU (1) HUP0003681A1 (de)
NO (1) NO20001415L (de)
SK (1) SK4022000A3 (de)
WO (1) WO1999015196A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005530683A (ja) 2001-12-21 2005-10-13 ノボ ノルディスク ヘルス ケア アクチェンゲゼルシャフト 第ｖｉｉ因子ポリペプチドの液体組成物
CA2475738A1 (en) * 2002-03-08 2003-09-18 Eli Lilly And Company Activated protein c formulations
CN101912601B (zh) 2002-06-21 2012-08-29 诺和诺德医疗保健公司 因子vii多肽的稳定化固体组合物
US7897734B2 (en) 2003-03-26 2011-03-01 Novo Nordisk Healthcare Ag Method for the production of proteins
KR20060015574A (ko) 2003-05-23 2006-02-17 노보 노르디스크 헬스 케어 악티엔게젤샤프트 용액 중 단백질 안정화
ES2382157T3 (es) 2003-06-25 2012-06-05 Novo Nordisk Health Care Ag Composición líquida de polipépttidos del factor VII
EP1656158B1 (de) 2003-08-14 2016-03-09 Novo Nordisk Health Care AG Flüssige, wässrige pharmazeutische zusammensetzung von faktor-vii-polypeptiden
EP2311437A1 (de) 2003-12-19 2011-04-20 Novo Nordisk Health Care AG Stabilisierte Zusammensetzungen von Faktor-VII-Polypeptiden
US20080260858A1 (en) * 2005-02-16 2008-10-23 The Board Of Trustees Of The University Of Illnois Universal Procoagulant
CA2600907C (en) 2005-03-04 2016-06-28 The Board Of Trustees Of The University Of Illinois Coagulation and fibrinolytic cascades modulator
US8821861B2 (en) 2007-10-05 2014-09-02 The Board Of Trustees Of The University Of Illinois Fibrin sealant
WO2009061697A1 (en) 2007-11-09 2009-05-14 The Board Of Trustees Of The University Of Illinois Anticoagulant antagonist and hemophilia procoagulant
EP4328305A3 (de) 2009-12-18 2024-08-14 CSL Ltd. Verfahren zur reinigung von polypeptiden
DK2624859T3 (en) * 2010-10-06 2017-06-06 Medimmune Ltd FACTOR II ALONE OR IN COMBINATION WITH OTHER FACTORS FOR TREATMENT OF REDUCED HEMOSTASE IN CONNECTION WITH DILUTION COAGULOPATHY
SG10201912497WA (en) * 2017-02-09 2020-02-27 Csl Behring Gmbh A blood coagulation factor replacement product for use in the treatment or prophylaxis of bleedings

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8729822D0 (en) * 1987-12-22 1988-02-03 Central Blood Lab Authority Chemical process
IT1262899B (it) * 1992-03-27 1996-07-22 Sclavo Spa Processo per l'isolamento di fattore ix, fattore x e fattore ii altamente purificati dal complesso protrombinico o dal plasma umano
DE4342132C1 (de) * 1993-12-10 1994-11-03 Octapharma Ag Verfahren zur Herstellung virusinaktivierte Vitamin K abhängige Plasmakomponenten sowie Protein C und Protein S enthaltender Mittel durch Membran-Chromatographie
DE4430205A1 (de) * 1994-08-26 1996-02-29 Behringwerke Ag Zusammensetzungen, die als Gegenmittel für Blut-Antikoagulanzien geeignet sind und deren Verwendung
SI0796623T1 (en) * 1996-03-20 2005-10-31 Baxter Aktiengesellschaft Pharmaceutical preparation for the treatment of blood coagulation disorders

Also Published As

Publication number Publication date
SK4022000A3 (en) 2000-09-12
WO1999015196A1 (de) 1999-04-01
JP2001517636A (ja) 2001-10-09
EP1015020A1 (de) 2000-07-05
AU743102B2 (en) 2002-01-17
BR9812222A (pt) 2000-07-18
AT409334B (de) 2002-07-25
NO20001415L (no) 2000-05-19
NO20001415D0 (no) 2000-03-17
CA2304396A1 (en) 1999-04-01
AU9244998A (en) 1999-04-12
HUP0003681A1 (hu) 2001-02-28

Similar Documents

Publication Publication Date Title
DE69831620D1 (de) Arzneizubereitungen enthaltend Kannabinoide
DK1090128T3 (da) Modificerede vitamin K-afhængige polypeptider
DE69814091D1 (de) Voriconazol-enthaltende pharmazeutische zubereitungen
NO20001776L (no) Medikamenter
PT1124779E (pt) Analogos da vitamina d
ID24654A (id) Formulasi farmasi omeprazola
DE69833739D1 (de) Kosmetisches Präparat
ID23299A (id) Formulasi-formulasi farmasi
DK1466615T3 (da) Farmaceutisk præparat
IS5536A (is) Efnablanda fyrir snyrtivörur
PT1235777E (pt) Analogos da vitamina d
IS4774A (is) Lyfjafræðilegar samsetningar með D-vítamín hliðstæðum
NO20001415D0 (no) Farmasøytikum inneholdende vitamin-K-avhengige faktorer
IS5331A (is) Ný lyfjablanda
PT1235824E (pt) Analogos da vitamina d
ATE298576T1 (de) Arzneizubereitungen
ZA982073B (en) Pharmaceutical preparation
EE03511B1 (et) Misolastiini sisaldavad prolongeeritud toimega farmatseutilised preparaadid
ATA6897A (de) Präparation umfassend thiolgruppen-hältige proteine
ID25857A (id) Komposisi farmasi
ATE237309T1 (de) Arzneizubereitungen
EP1142589A4 (de) Medizinische zusammensetzungen
DE59807819D1 (de) Duftstoff-enthaltende Zubereitung
DE69809375D1 (de) Antikrebs-Zubereitung
ID23663A (id) Persiapan kaprolaktam

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee